Skip Navigation


Mol. Hum. Reprod. Advance Access originally published online on August 26, 2009
Molecular Human Reproduction 2009 15(11):703-711; doi:10.1093/molehr/gap067
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/11/703    most recent
gap067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rahman, N. A.
Right arrow Articles by Rao, C.V.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahman, N. A.
Right arrow Articles by Rao, C.V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Recent progress in luteinizing hormone/human chorionic gonadotrophin hormone research

Nafis A. Rahman1,2,3 and C.V. Rao2

1Department of Physiology, Faculty of Medicine, Institute of Biomedicine, University of Turku, FIN-20520 Turku, Finland 2Departments of Cell Biology, Molecular and Human Genetics, Obstetrics & Gynecology, Florida International University College of Medicine, Miami, FL 33199, USA

3 Correspondence address. Department of Physiology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. Fax: +358-2-2502610; E-mail: nafis.rahman{at}utu.fi

The role of luteinizing hormone (LH) and human chorionic gonadotrophin hormone (hCG) in the regulation of normal reproductive functions in males and females is quite well established. Besides the use of hCG in the development of diagnostic immunoassays, it has been successfully used in the induction of final follicular maturation and ovulation in the assisted reproductive technologies. The basic and clinical research on the nongonadal actions of LH/hCG in the recent years has extended the potential of using these hormones in several clinical indications. Hereby we will analyze the advances in the LH/hCG research (briefly emphasizing the nongonadal research), which has the potential for multiple novel therapies in reproductive and the other areas of medicine.

Key words: luteinizing hormone/human chorionic gonadotrophin/luteinizing/human chorionic gonadotrophin receptor/gonadal and nongonadal effects

Submitted on December 19, 2008; resubmitted on July 23, 2009; accepted on August 7, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.